Afr J Prim Health Care Fam Med
- NDAKUKAMO EK, Mahalie R, Hailonga-van Dijk P
Health system constraints in cervical cancer prevention in rural Namibia: A
qualitative study.
Afr J Prim Health Care Fam Med. 2025;17:e1-e9.
- POLANE MG, Dlamini SB
Exploring primary health care nurses' perceptions of cervical cancer screening in
Leribe, Lesotho.
Afr J Prim Health Care Fam Med. 2025;17:e1-e9.
Am J Case Rep
- YUAN J, Wang IT, Lin YH, Qiu JT, et al
Two Cases of Primary Melanoma of the Uterine Cervix.
Am J Case Rep. 2025;26:e948101.
- REN X, Wu J, Yang S, Wang Y, et al
Radiotherapy-Related Bladder Fistula: A Hidden Cause of Recurrent Abdominal
Symptoms.
Am J Case Rep. 2025;26:e948953.
Am J Clin Pathol
- DOXTADER EE, Ooms K, Brainard JA, Policarpio-Nicolas MLC, et al
Papanicolaou test interpretation utilizing the Hologic Genius Digital Diagnostics
System vs manual glass slide review: A retrospective study of 596 cases.
Am J Clin Pathol. 2025;164:513-521.
Anal Sci
- LIN M, Zou Y, Yu L, Xiao H, et al
An immunoassay based on polyHRP signal amplification for HPV16/18 E6 RNA
detection with anti-DNA-RNA hybrid antibody.
Anal Sci. 2025;41:1461-1471.
Ann Behav Med
- HUA J, Klein WMP, Acevedo AM
Sociocultural correlates of cervical cancer prevention behaviors among
Hispanic/Latina women in the United States.
Ann Behav Med. 2025;59:kaaf069.
Arch Gynecol Obstet
- VAN COOTEN VV, van Hamont D, Siebers AG, Alcala L, et al
The prevalence and clinical relevance of cervical abnormalities after an
amputation of the cervix as part of prolapse surgery: a cross-sectional study.
Arch Gynecol Obstet. 2025;312:1287-1294.
- EHLERS U, Hoischen L, Stalp JL, Hachenberg J, et al
The treatment of cervical intraepithelial neoplasia grade 2 (HSIL): between
active surveillance and surgery-a 10-year monocentric data analysis.
Arch Gynecol Obstet. 2025;312:1125-1132.
BMJ Open
- CHONG L, Zou Z, Xia L, Wang X, et al
p16 expression and its correlation with the clinical pathological characteristics
of patients with cervical cancer: a systematic review and meta-analysis.
BMJ Open. 2025;15:e102602.
- LEMA TF, Mosalo A, Moleki M
Perceived risk of human papillomavirus infection and cervical cancer: a
qualitative study among Ethiopian women.
BMJ Open. 2025;15:e103895.
Br J Cancer
- GORI S, Venturelli F, Carozzi F, Giorgi Rossi P, et al
Italian guidelines for cervical cancer screening. Multisocietal recommendations
on the use of biomarkers in HPV screening with risk-based approach and GRADE
methodology.
Br J Cancer. 2025 Sep 11. doi: 10.1038/s41416-025-03161.
Brachytherapy
- KOMORI S, Takagawa Y, Sato H, Machida M, et al
A novel dose-based intra-preplan method for high-dose-rate brachytherapy in
cervical cancer using modeling and optimization algorithms.
Brachytherapy. 2025 Sep 6:S1538-4721(25)00250.
Cell Signal
- AN S, Han A, Lin Z, Quan H, et al
Targeting ferroptosis in cervical cancer: Mechanistic insights and therapeutic
opportunities.
Cell Signal. 2025 Sep 10:112122. doi: 10.1016/j.cellsig.2025.112122.
Cien Saude Colet
- VIEIRA JR, Azize R, Nucci MF
[Between gender and health technologies: an analysis of HPV and cervical cancer
prevention campaigns from 2014 to 2020].
Cien Saude Colet. 2025;30:e04072024.
Cochrane Database Syst Rev
- KAPP P, Schmucker C, Siemens W, Brugger T, et al
Human papillomavirus (HPV) vaccination in women with conisation.
Cochrane Database Syst Rev. 2025;9:CD016121.
Comput Methods Programs Biomed
- KHARE SK, Booth BB, Blanes-Vidal V, Petersen LK, et al
An explainable attention model for cervical precancer risk classification using
colposcopic images.
Comput Methods Programs Biomed. 2025;271:108976.
Cureus
- VERMA R, Sharma R, Mishra P, Mishra N, et al
Opportunistic Cervical Cancer Screening During Antenatal Visits: A Small Step
Toward Early Detection.
Cureus. 2025;17:e89433.
- YADAV J, Gupta S, Venugopal AK, Ghosh A, et al
3D Conformal Radiotherapy Versus the Conventional Box Technique for Cervical
Cancer: A Dosimetric Observational Study.
Cureus. 2025;17:e89799.
Curr Pharm Des
- ZOGHEBI K, Jali AM
Flavonoids as Dual Inhibitors of MELK and LYN Kinases in Cervical Cancer: An In
Silico Molecular Docking Analysis.
Curr Pharm Des. 2025 Sep 5. doi: 10.2174/0113816128387273250823102532.
Environ Health Prev Med
- LI YM, Zhao QL, Ogawa R, Mizukami T, et al
Synergistic inhibition of autophagic flux and induction of apoptosis in cervical
cancer cells by Mito-TEMPO and hyperthermia.
Environ Health Prev Med. 2025;30:67.
Epidemiol Serv Saude
- FREITAS AKMSO, Camargo JDAS, Souza ATB, Pontes THA, et al
Sociodemographic and clinical factors associated with delayed diagnosis of
cervical cancer: a cross-sectional study, Brazil, 2016-2020.
Epidemiol Serv Saude. 2025;34:e20240764.
Eur J Obstet Gynecol Reprod Biol
- KIM S, Kwon G, Kim H, Yun H, et al
Full-term delivery after antepartum vaginal myomectomy for prolapsed myoma
causing uterus distortion: A case report and literature review.
Eur J Obstet Gynecol Reprod Biol. 2025;313:114580.
- KEERTHANA A, Anantharaju A, Ansar PTM, Kala, et al
Real-time detection of premalignant cervical lesion using Artificial Intelligence
(AI) model in multispectral imaging system.
Eur J Obstet Gynecol Reprod Biol. 2025;313:114579.
Front Immunol
- DONG Y, Zhang X, Zhao J, Hou Q, et al
Glycan dysregulation as one of major metabolic subtypes is associated with TERC
overexpression and poor outcomes in cervical cancer.
Front Immunol. 2025;16:1585647.
Front Oncol
- LIU C, Li X, Deng Y
Case Report: Immune-mediated acute liver failure induced by tislelizumab in a
patient with advanced cervical cancer.
Front Oncol. 2025;15:1604601.
- CUI N, Zhang Y, Zhang Y, Wang L, et al
TRIM31 acts as an intermediate molecule in the process by which Snai2 impairs the
proliferation of cervical cancer cells.
Front Oncol. 2025;15:1537991.
- XIE C, Liu H, Huang D, Zhao G, et al
Case Report: Cervical cancer masquerading as ovarian tumor: diagnostic challenges
in a case with severe pyometra-pyocolpos complex.
Front Oncol. 2025;15:1647366.
- WANG X, Wang C, Zong D, Zhu B, et al
First-line treatment with cadonilimab plus paclitaxel-platinum +/- bevacizumab for
persistent, recurrent, or metastatic cervical cancer: a retrospective real-world
study.
Front Oncol. 2025;15:1634779.
- SHI P, Zhang W, Yao Q, Yuan Z, et al
CS Ratio is an immune-related prognostic biomarker for cervical cancer.
Front Oncol. 2025;15:1547529.
Hum Vaccin Immunother
- FU X, Zhang Q, Wagner AL, Zhou W, et al
Cost-effectiveness and epidemiological impact of gender-neutral vaccination
against human papillomavirus in economically developed metropolises of Beijing,
Shanghai, and Guangzhou, China.
Hum Vaccin Immunother. 2025;21:2557092.
Indian J Clin Biochem
- LI Z, Wang H, Yang R, Jin X, et al
Plasma-Derived Exosomal tRF-Phe-GAA-001 and tRF-Gly-GCC-037 as Novel Diagnostic
Biomarkers for Cervical Cancer.
Indian J Clin Biochem. 2025;40:683-690.
Int J Cancer
- LIU Z, Tong X
Comments on "HPV vaccination is highly effective and cost-effective for cervical
cancer prevention in women living with HIV in China: A cost-effectiveness
analysis".
Int J Cancer. 2025 Sep 9. doi: 10.1002/ijc.70130.
- LIU H, Zou Z, Zhang L
Reply to 'Comments on "HPV vaccination is highly effective and cost-effective for
cervical cancer prevention in women living with HIV in China: A
cost-effectiveness analysis"'.
Int J Cancer. 2025 Sep 9. doi: 10.1002/ijc.70129.
- CASTANEDA KM, Vermeulen KM, van der Aa M, Schuuring E, et al
Trends in cervical cancer incidence in the Netherlands: A join-point and
age-period-cohort analysis (1989-2023).
Int J Cancer. 2025 Sep 8. doi: 10.1002/ijc.70134.
Int J Gen Med
- LI Y, Cai L, Zhou J, Zhang X, et al
RCN1 Binds KIF14 and Promotes the Malignant Growth of Cervical Cancer Through the
PI3K-AKT Pathway.
Int J Gen Med. 2025;18:5047-5062.
Int J Gynecol Cancer
- ISMAIL M, Refky B, Mostafa N, Elazab M, et al
From silence to action: Egypt's path to national cervical cancer prevention.
Int J Gynecol Cancer. 2025 Aug 26:102121. doi: 10.1016/j.ijgc.2025.102121.
Int J Radiat Oncol Biol Phys
- PAI V, Wairkar T, Menon S, Chaudhari S, et al
PD-L1 expression in locally advanced cervical cancer: A pilot cross clone
comparison study.
Int J Radiat Oncol Biol Phys. 2025 Sep 4:S0360-3016(25)06207.
IUBMB Life
- WANG W, Deng Y, Feng Y, Chen R, et al
Unveiling Gamma-Interferon-Inducible Lysosomal Thiol Reductase (IFI30) as a
Regulator of Macrophage Polarization and Prognostic Biomarker by
Multi-Transcriptome Analysis in Cervical Cancer.
IUBMB Life. 2025;77:e70056.
J Biomed Inform
- ATLAS SJ, Burdick TE, Wright A, Zhao W, et al
Comparing clinical decision support systems for improving follow-up of abnormal
cervical cancer screening test results.
J Biomed Inform. 2025 Sep 9:104908. doi: 10.1016/j.jbi.2025.104908.
J Cancer Res Clin Oncol
- M EL-DOUSHY A, Attalla EM, Ibrahim IH, El-Sayed SM, et al
Dosimetry evaluation and uncertainty analysis of Cobalt-60 HDR brachytherapy for
cervical cancer in resource-limited settings.
J Cancer Res Clin Oncol. 2025;151:247.
J Christ Nurs
- MINCHEW LA
Self-Blame Attribution: Concept Analysis and Application to HPV-Related Cancers.
J Christ Nurs. 2025;42:216-223.
J Clin Virol
- OSTRBENK A, Pedersen H, Poljak M, Bonde J, et al
The Allplex HPV HR Detection assay fulfils international guideline requirements
for primary cervical screening on SurePath samples and qualifies as a
second-generation HPV comparator test.
J Clin Virol. 2025;180:105853.
J Gynecol Oncol
- CEN Y, Tu M, Zhang Y, Ren Y, et al
A novel non-invasive mRNA-lncRNA biomarker panel for accurate prediction of
cervical squamous cell carcinoma and adenocarcinoma.
J Gynecol Oncol. 2025;36:e81.
J Infect Dev Ctries
- CELA M, Gjata E, Sinaj E, Ndreu V, et al
The influence of parents' knowledge on HPV vaccine uptake - evidence from
Albania.
J Infect Dev Ctries. 2025;19:1231-1238.
J Int Med Res
- ZHU H, Zhu H, Bao Y
Multiple injections of indocyanine green for improving the outcomes of
lymphatic-venous anastomosis reconstruction of lymphatic return under microscopy:
A case report.
J Int Med Res. 2025;53:3000605251375258.
J Obstet Gynaecol Can
- JIANG H, Chen X
Vulvar cancer combined with cervical cancer.
J Obstet Gynaecol Can. 2025 Sep 10:103105. doi: 10.1016/j.jogc.2025.103105.
J Proteome Res
- HAO Y, Liu Q, Wang B, Zhang W, et al
Proteomics-Based Mapping of the Lymph Node Metastasis Landscape in Cervical
Cancer.
J Proteome Res. 2025 Sep 11. doi: 10.1021/acs.jproteome.5c00570.
J Relig Health
- BAKAN ABS, Aslan G, Basaran F
An Investigation of the Effect of Education Interventions Given to Women in
Turkey with Religious Orientation on Cervical Cancer and Pap Smear Test Health
Beliefs.
J Relig Health. 2025 Sep 7. doi: 10.1007/s10943-025-02435.
J Womens Health (Larchmt)
- ZANWAR PP
Cervical Cancer Screening: Perspectives from an Interdisciplinary Lens to Inform
Future Research, Practice, Policy, and Intervention Strategies.
J Womens Health (Larchmt). 2025 Sep 8. doi: 10.1177/15409996251370876.
- HARPER DM, Anderson PF, James LN, Alves M, et al
A Scoping Review of Women with Physical Disabilities and Cervical Cancer
Screening.
J Womens Health (Larchmt). 2025 Sep 8. doi: 10.1177/15409996251374587.
JAMA Netw Open
- DAMGACIOGLU H, Curtis C, Sonawane K, Clifford G, et al
Anal Cancer Incidence Among Women With a History of Cervical Cancer by Age and
Time Since Diagnosis.
JAMA Netw Open. 2025;8:e2531362.
JCO Glob Oncol
- OKUNADE KS, Fayinto AI, Adekanye TV, Allsop MJ, et al
Randomized Controlled Trial of Impact of Mobile Health Technologies on Human
Papillomavirus Vaccination Uptake in Mothers of Vaccine-Eligible Girls in Lagos,
Nigeria (mHealth-HPVac).
JCO Glob Oncol. 2025;11:e2500150.
JMIR Cancer
- LI S, Guo C, Fang Y, Qiu J, et al
Machine Learning for Preoperative Assessment and Postoperative Prediction in
Cervical Cancer: Multicenter Retrospective Model Integrating MRI and
Clinicopathological Data.
JMIR Cancer. 2025;11:e69057.
Kaohsiung J Med Sci
- GAO Y, Zou T
Hypoxia Triggers ALYREF-Mediated m(5)C Methylation of KIF20A to Activate
KIF20A/BUB1 for Generating Ferroptosis Resistance in Cervical Cancer Cells.
Kaohsiung J Med Sci. 2025 Sep 7:e70093. doi: 10.1002/kjm2.70093.
Medicine (Baltimore)
- CHEN Z, Zhang L, Li D, Zhu R, et al
Treatment of advanced cervical cancer with Cinobufacini and Paclitaxel-Cisplatin
combination: A meta-analysis.
Medicine (Baltimore). 2025;104:e44146.
Nutr Clin Pract
- TIAN M, Yuan Z, Wang H, Liu T, et al
The cachexia index as a prognostic indicator in patients with cervical cancer
treated with radiotherapy: A retrospective study.
Nutr Clin Pract. 2025 Sep 10. doi: 10.1002/ncp.70032.
Obstet Gynecol
- TERGAS AI, Einstein MH
The Future of Cervical Cancer Screening Is Now.
Obstet Gynecol. 2025;146:3-5.
Oncol Lett
- REN L, Zhang J, Yang J, Ji L, et al
YTHDC2 inhibits HPV-positive cervical cancer growth by suppressing SLC7A11 in a
ferroptosis-dependent manner.
Oncol Lett. 2025;30:498.
Open Med (Wars)
- WU J, Xu Q, Huang H, Pang Y, et al
Risk and prognosis for brain metastasis in primary metastatic cervical cancer
patients: A population-based study.
Open Med (Wars). 2025;20:20251165.
Phys Med Biol
- NIYOTEKA S, Rouhi R, Laurent PA, Achkar S, et al
GAN-based standardization of MR images: a promising approach for the development
of multicentre radiomic models.
Phys Med Biol. 2025;70.
PLOS Glob Public Health
- ADHIAMBO HF, Owidi E, Okello P, Coe M, et al
Barriers and facilitators to implementing a single-visit, screen-and-treat
approach with thermal ablation for cervical cancer prevention in Kenya.
PLOS Glob Public Health. 2025;5:e0005166.
- BILALAGA MM, Gaddipati G, Devkota A, Vasireddy R, et al
HPV knowledge and non-adherence to cervical cancer screening before and following
the COVID-19 pandemic in the United States.
PLOS Glob Public Health. 2025;5:e0004800.
PLoS One
- OLUBODUN T, Olaniran A, Awowole IO, Ohazurike E, et al
Practice of opportunistic cervical cancer screening and health education among
health workers in Ogun State, Nigeria: A qualitative study of barriers and
facilitators.
PLoS One. 2025;20:e0316883.
- MWANGI JH, Mbeje PN, Mtshali GN
Exploring the roles of male partners in the transmission, prevention and control
of cervical cancer in Central Kenya: A qualitative study.
PLoS One. 2025;20:e0324575.
- JAFRIN S, Aziz MA, Barek MA, Reza MS, et al
Association of missense variant DCLRE1B rs3761936 with breast and cervical cancer
risk-A case-control study.
PLoS One. 2025;20:e0331492.
- WYNN A, Harris D, Modest A, Reyes MF, et al
Short-term costs and cost-efficiency of HPV triage strategies in a high
HIV-prevalence setting: Evidence from Botswana.
PLoS One. 2025;20:e0328803.
- KHIRUDDIN K, Mustafa WA, Islam MA, Jamaludin KR, et al
Comparative analysis of cervical cancer classification of DPAGCHE-enhanced Pap
smear images using convolutional neural network models.
PLoS One. 2025;20:e0330103.
Pol Merkur Lekarski
- HRYNEVYCH OY
Human papillomavirus: problems and prospects for women's reproductive health
(systematic review).
Pol Merkur Lekarski. 2025;53:546-554.
Psychooncology
- CHONA EZ, Gosse RA, Msengi EA, Aruldhas TP, et al
Life Experiences of Women Diagnosed With Cervical Cancer in Sub-Saharan Africa: A
Systematic Review of Qualitative Studies.
Psychooncology. 2025;34:e70280.
Rep Pract Oncol Radiother
- PATRE P, Verma D
Deep dive into deep learning methods for cervical cancer detection and
classification.
Rep Pract Oncol Radiother. 2025;30:396-416.
- PATRE P, Verma D
Optimizing cervical cancer diagnosis with accurate cell classification using
modified HDFF.
Rep Pract Oncol Radiother. 2025;30:316-331.
Rev Cuid
- DE OLIVEIRA SERRA TOCHETTO L, Meimei Brevidelli M, Rodrigues Santos T, Samora de Almeida M, et al
Quality of cervical cancer screening in a Brazilian sample: cross-sectional
study.
Rev Cuid. 2025;16:e3597.
Strahlenther Onkol
- AUTORINO R, Macchia G, Russo L, Dinapoli N, et al
Which is the best timing to assess response after chemoradiation in locally
advanced cervical cancer (BRILACC)?
Strahlenther Onkol. 2025 Sep 12. doi: 10.1007/s00066-025-02463.
Support Care Cancer
- DUAN S, Su Y, Niu Q, Wei J, et al
Construction and implementation of a nursing intervention program based on
supportive care theory for cervical cancer patients receiving postoperative
concurrent chemoradiotherapy.
Support Care Cancer. 2025;33:845.
Womens Health (Lond)
- CHEN R, Ye C, Li Y, Lin Z, et al
Analysis of follow-up outcomes in patients with cervical histologic low-grade
squamous intraepithelial lesion preceded by serious cytology and repeated
diagnosis for at least 2 years.
Womens Health (Lond). 2025;21:17455057251374504.
Womens Health Issues
- OLSON A, Fuzzell L, Brownstein NC, Fontenot HB, et al
Factors Associated With Guideline-Concordant Cervical Cancer Screening Exit: A
Mixed Methods Study.
Womens Health Issues. 2025 Sep 8:S1049-3867(25)00102.